A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women.
This is an early-stage research study, called a Phase I trial, looking into a new version of a drug called letrozole, which is labelled as LEBE. The main goal is to understand how a healthy post-menopausal woman's body takes in, processes, and gets rid of this new medicine. Researchers also want to make sure it's safe and doesn't cause any unexpected problems. This kind of study is very important because it's the first step in testing a new drug in people. The information gathered helps scientists understand if this new form of letrozole could be a good candidate for treating certain conditions in the future. It’s part of a careful process to make sure new medicines are both effective and safe for patients.
At a glance
What is this study about?
Imagine scientists are developing a new type of medicine. Before it can be used to treat illnesses, they need to thoroughly test it. This study is an important early step in that process. It's called a 'Phase I' study, which means it's one of the very first times this specific version of the medicine, called letrozole LEBE, is being given to people, not just animals.
The main purpose of this study is to carefully watch what happens when healthy women who have gone through menopause take this new medicine. The researchers want to understand two key things: first, how the body absorbs, uses, and gets rid of the medicine (this is called 'pharmacokinetics'). Think of it like seeing how a new type of fuel works in a car – how much it uses, how long it lasts, and what comes out. Second, they want to make sure the medicine is safe and doesn't cause any serious side effects. This is the main reason these early studies use healthy volunteers – to check for safety before moving on to people who might be unwell.
This study will help gather crucial information that will decide if this new form of letrozole can be tested further in larger studies, eventually for conditions it might treat. It's a foundational step to ensure any new medicine has the best chance of being both effective and safe for future patients. By taking part in such a study, volunteers contribute significantly to medical progress.
Key takeaways
- This is an early-stage safety and body processing study of new medicine (Letrozole LEBE).
- It's for healthy women who have gone through menopause.
- The main goals are to check safety and how the body handles the medicine.
- Participation helps scientists learn about potential future treatments.
- You'll be closely monitored throughout the study.
- You can stop participating at any time.
Who may be eligible?
This study is specifically looking for women who have naturally stopped having their periods, meaning they have gone through menopause. You need to be at least 18 years old or older to take part.
Because this is a study about how a new medicine works in healthy people, you also need to be in generally good health. This means you shouldn't have any major ongoing health problems or illnesses that could affect how your body handles the medicine or make taking part unsafe.
The research team will carry out some checks to make sure you fit all the requirements for taking part and that it would be safe for you. They will explain everything clearly before you make any decisions.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am a woman.
- I have gone through menopause (my periods have stopped).
- I am at least 18 years old.
- I am generally in good health.
- I am willing to follow all study instructions and attend appointments.
What does participation involve?
We don’t have all the specific details about what taking part in this particular study involves, as the summary provided was very brief. However, for a typical Phase I study like this, you would likely have an initial screening visit where doctors check your health to make sure you're suitable. If you qualify, you would then attend the study centre for the main part of the study.
This could involve staying at the research clinic for a few days or making several visits over a period of time. You would be given the study medication, letrozole LEBE, and the research team would closely monitor you. This usually includes having regular blood tests to see how the medicine is moving through your body, and checks of your vital signs like blood pressure and heart rate. You might also be asked to complete questionnaires about how you are feeling.
After you've taken the medicine, there might be follow-up visits or phone calls to make sure you continue to be well and to check for any delayed effects. The total length of your involvement would be explained to you in detail before you decide to join.
Potential risks and benefits
Locations (2)
- —UnverifiedCzechia
- —UnverifiedBulgaria
Common questions
What does 'post-menopausal' mean?
It means you have naturally stopped having menstrual periods, usually for at least 12 consecutive months.
What is 'Phase I' in a clinical trial?
Phase I is the very first stage where a new medicine is tested in people, usually healthy volunteers, to check its safety and how the body handles it.
Will I get 'letrozole LEBE' or a dummy pill?
In a study focused on how a drug works in healthy people, you would typically receive the active drug. The study team will confirm this.
Will I need to stay overnight?
Some Phase I studies involve overnight stays for close monitoring, especially after taking the medicine. The research team will provide full details.
Do I have to pay to join this study?
No, you should never have to pay to take part in a clinical trial. Sometimes volunteers are reimbursed for their time and travel expenses.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.